Editas Medicine, Inc. SEC filings EDIT
Editas Medicine, Inc. has 727 filings in SEC EDGAR's recent list, going back to Aug 18, 2015. Its latest annual report, Form ARS, was filed on Apr 28, 2026 for the period ended Apr 28, 2026. The latest quarterly report (Form 10-Q) was filed on Aug 5, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 8, 2026 (regulation fd disclosure, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| SCHEDULE 13G | Ownership over 5% (passive) | Oct 27, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Oct 8, 2026 | Oct 8, 2026 |
| 4 | Insider transaction | Sep 9, 2026 | Sep 8, 2026 |
| 3 | Initial insider ownership | Sep 9, 2026 | Sep 8, 2026 |
| S-8 | Employee stock plan registration | Sep 9, 2026 | — |
| EFFECT | Filing | Sep 8, 2026 | — |
| 4 | Insider transaction | Sep 4, 2026 | Sep 3, 2026 |
| 4 | Insider transaction | Sep 4, 2026 | Sep 3, 2026 |
| 4 | Insider transaction | Sep 4, 2026 | Sep 3, 2026 |
| S-3 | Shelf registration | Aug 31, 2026 | — |
| 144 | Notice of proposed sale | Aug 31, 2026 | — |
| 144 | Notice of proposed sale | Aug 31, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Aug 14, 2026 | — |
| 4 | Insider transaction | Aug 7, 2026 | Aug 6, 2026 |
| 3 | Initial insider ownership | Aug 7, 2026 | Aug 6, 2026 |
| 4 | Insider transaction | Aug 5, 2026 | Aug 3, 2026 |
| 10-Q | Quarterly report | Aug 5, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations, Officer or director change
|
Aug 5, 2026 | Aug 3, 2026 |
| 4 | Insider transaction | Jul 29, 2026 | Jul 28, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jul 29, 2026 | — |
| 144 | Notice of proposed sale | Jul 21, 2026 | — |
| 4 | Insider transaction | Jun 22, 2026 | Jun 17, 2026 |
| 4 | Insider transaction | Jun 22, 2026 | Jun 17, 2026 |
| 4 | Insider transaction | Jun 22, 2026 | Jun 17, 2026 |
| 4 | Insider transaction | Jun 22, 2026 | Jun 17, 2026 |
| 4 | Insider transaction | Jun 22, 2026 | Jun 17, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 18, 2026 | Jun 17, 2026 |
| 4 | Insider transaction | Jun 5, 2026 | Jun 3, 2026 |
| 4 | Insider transaction | Jun 5, 2026 | Jun 3, 2026 |
| 4 | Insider transaction | Jun 5, 2026 | Jun 3, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Jun 3, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Jun 3, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Jun 2, 2026 | — |
| 144 | Notice of proposed sale | May 29, 2026 | — |
| 424B5 | Prospectus supplement | May 26, 2026 | — |
| 8-K |
Current report
Material agreement, Other events
|
May 26, 2026 | May 26, 2026 |
| S-3MEF | Filing | May 26, 2026 | — |
| 8-K |
Current report
Other events
|
May 26, 2026 | May 26, 2026 |
| 424B5 | Prospectus supplement | May 26, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
May 26, 2026 | May 25, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
May 14, 2026 | May 14, 2026 |
| 10-Q | Quarterly report | May 5, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
May 5, 2026 | May 5, 2026 |
| ARS | Annual report to shareholders | Apr 28, 2026 | Apr 28, 2026 |
| DEFA14A | Additional proxy material | Apr 28, 2026 | — |
| DEF 14A | Proxy statement | Apr 28, 2026 | Apr 28, 2026 |
| 8-K |
Current report
Auditor change
|
Apr 7, 2026 | Apr 1, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Mar 27, 2026 | Mar 26, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Mar 26, 2026 | — |
| 4 | Insider transaction | Mar 16, 2026 | Mar 12, 2026 |
| 4 | Insider transaction | Mar 16, 2026 | Mar 12, 2026 |
| 4 | Insider transaction | Mar 16, 2026 | Mar 12, 2026 |
| 10-K | Annual report | Mar 9, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 9, 2026 | Mar 9, 2026 |
| 4 | Insider transaction | Mar 4, 2026 | Mar 3, 2026 |
| 4 | Insider transaction | Mar 4, 2026 | Mar 3, 2026 |
| 4 | Insider transaction | Mar 4, 2026 | Mar 3, 2026 |
| 144 | Notice of proposed sale | Feb 27, 2026 | — |
| 4 | Insider transaction | Dec 4, 2025 | Dec 3, 2025 |
| 4 | Insider transaction | Dec 4, 2025 | Dec 3, 2025 |
| 4 | Insider transaction | Dec 4, 2025 | Dec 3, 2025 |
| 144 | Notice of proposed sale | Dec 1, 2025 | — |
| 10-Q | Quarterly report | Nov 10, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 10, 2025 | Nov 10, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Oct 9, 2025 | Oct 9, 2025 |
| 4 | Insider transaction | Sep 4, 2025 | Sep 3, 2025 |
| 4 | Insider transaction | Sep 4, 2025 | Sep 3, 2025 |
| 4 | Insider transaction | Sep 4, 2025 | Sep 3, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 2, 2025 | Sep 2, 2025 |
| 144 | Notice of proposed sale | Aug 29, 2025 | — |
| 144 | Notice of proposed sale | Aug 29, 2025 | — |
| 10-Q | Quarterly report | Aug 12, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 12, 2025 | Aug 12, 2025 |
| 4 | Insider transaction | Aug 8, 2025 | Aug 7, 2025 |
| 4 | Insider transaction | Aug 4, 2025 | Jul 31, 2025 |
| 144 | Notice of proposed sale | Jul 30, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 12, 2025 | Jun 12, 2025 |
| 4 | Insider transaction | Jun 10, 2025 | Jun 6, 2025 |
| 4 | Insider transaction | Jun 10, 2025 | Jun 6, 2025 |
| 4 | Insider transaction | Jun 10, 2025 | Jun 6, 2025 |
| 4 | Insider transaction | Jun 10, 2025 | Jun 6, 2025 |
| 4 | Insider transaction | Jun 10, 2025 | Jun 6, 2025 |
| 4 | Insider transaction | Jun 4, 2025 | Jun 3, 2025 |
| 4 | Insider transaction | Jun 4, 2025 | Jun 3, 2025 |
| 4 | Insider transaction | Jun 4, 2025 | Jun 3, 2025 |
| 144 | Notice of proposed sale | Jun 2, 2025 | — |
| 8-K |
Current report
Officer or director change, Bylaw or fiscal year change, Shareholder vote results
|
Jun 2, 2025 | May 29, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
May 14, 2025 | May 14, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
May 13, 2025 | May 13, 2025 |
| 10-Q | Quarterly report | May 12, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 12, 2025 | May 12, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Apr 17, 2025 | — |
| ARS | Annual report to shareholders | Apr 15, 2025 | Apr 15, 2025 |
| DEFA14A | Additional proxy material | Apr 15, 2025 | — |
| DEF 14A | Proxy statement | Apr 15, 2025 | Apr 15, 2025 |
| 4 | Insider transaction | Apr 8, 2025 | Apr 8, 2025 |
| 3 | Initial insider ownership | Apr 8, 2025 | Mar 28, 2025 |
| PRE 14A | Preliminary proxy statement | Apr 4, 2025 | Apr 4, 2025 |
| 4 | Insider transaction | Mar 27, 2025 | Mar 8, 2025 |
| 4 | Insider transaction | Mar 27, 2025 | Mar 8, 2025 |
| 4 | Insider transaction | Mar 27, 2025 | Mar 8, 2025 |
| EFFECT | Filing | Mar 21, 2025 | — |
| 8-K |
Current report
Officer or director change
|
Mar 20, 2025 | Mar 18, 2025 |
| POS AM | Filing | Mar 5, 2025 | — |
| 4 | Insider transaction | Mar 5, 2025 | Mar 4, 2025 |
| 4 | Insider transaction | Mar 5, 2025 | Mar 4, 2025 |
| 4 | Insider transaction | Mar 5, 2025 | Mar 4, 2025 |
| S-8 | Employee stock plan registration | Mar 5, 2025 | — |
| 10-K | Annual report | Mar 5, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 5, 2025 | Mar 5, 2025 |
| POSASR | Filing | Mar 5, 2025 | — |
| 144 | Notice of proposed sale | Feb 28, 2025 | — |
| 144 | Notice of proposed sale | Feb 28, 2025 | — |
| 144 | Notice of proposed sale | Feb 28, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 14, 2025 | — |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jan 13, 2025 | Jan 13, 2025 |
| 8-K |
Current report
Officer or director change
|
Dec 17, 2024 | Dec 16, 2024 |
| 8-K |
Current report
Exit or restructuring costs, Officer or director change, Regulation FD disclosure, Other events
|
Dec 12, 2024 | Dec 11, 2024 |
| 8-K |
Current report
Bylaw or fiscal year change, Regulation FD disclosure
|
Dec 10, 2024 | Dec 6, 2024 |
| 4 | Insider transaction | Dec 5, 2024 | Dec 3, 2024 |
| 4 | Insider transaction | Dec 5, 2024 | Dec 3, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 12, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 4, 2024 | — |
| 10-Q | Quarterly report | Nov 4, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 4, 2024 | Nov 4, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Oct 22, 2024 | Oct 22, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Oct 17, 2024 | — |
| 8-K |
Current report
Material agreement, New debt, Regulation FD disclosure
|
Oct 4, 2024 | Oct 3, 2024 |
| 4 | Insider transaction | Sep 6, 2024 | Sep 4, 2024 |
| 4 | Insider transaction | Sep 6, 2024 | Sep 4, 2024 |
| 144 | Notice of proposed sale | Aug 29, 2024 | — |
| 144 | Notice of proposed sale | Aug 29, 2024 | — |
| 10-Q | Quarterly report | Aug 7, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 7, 2024 | Aug 7, 2024 |
| 4 | Insider transaction | Jul 26, 2024 | Jul 25, 2024 |
| 4 | Insider transaction | Jul 22, 2024 | Jul 19, 2024 |
| 144 | Notice of proposed sale | Jul 18, 2024 | — |
| 144 | Notice of proposed sale | Jul 18, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Jul 10, 2024 | — |
| 8-K |
Current report
Officer or director change
|
Jun 27, 2024 | Jun 27, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 14, 2024 | Jun 14, 2024 |
| 4 | Insider transaction | Jun 6, 2024 | Jun 4, 2024 |
| 4 | Insider transaction | Jun 6, 2024 | Jun 4, 2024 |
| 4 | Insider transaction | Jun 3, 2024 | May 30, 2024 |
| 4 | Insider transaction | Jun 3, 2024 | May 30, 2024 |
| 4 | Insider transaction | Jun 3, 2024 | May 30, 2024 |
| 4 | Insider transaction | Jun 3, 2024 | May 30, 2024 |
| 4 | Insider transaction | Jun 3, 2024 | May 30, 2024 |
| 4 | Insider transaction | Jun 3, 2024 | May 30, 2024 |
| 4 | Insider transaction | Jun 3, 2024 | May 30, 2024 |
| 4 | Insider transaction | Jun 3, 2024 | May 30, 2024 |
| 144 | Notice of proposed sale | May 31, 2024 | — |
| 144 | Notice of proposed sale | May 31, 2024 | — |
| 8-K |
Current report
Shareholder vote results
|
May 31, 2024 | May 30, 2024 |
| 4 | Insider transaction | May 22, 2024 | May 20, 2024 |
| 144 | Notice of proposed sale | May 17, 2024 | — |
| 4 | Insider transaction | May 14, 2024 | May 13, 2024 |
| 10-Q | Quarterly report | May 8, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations
|
May 8, 2024 | May 8, 2024 |
| DEFA14A | Additional proxy material | Apr 16, 2024 | — |
| DEF 14A | Proxy statement | Apr 16, 2024 | Apr 16, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Apr 10, 2024 | — |
| 4 | Insider transaction | Mar 5, 2024 | Mar 2, 2024 |
| 4 | Insider transaction | Mar 5, 2024 | Mar 2, 2024 |
| 4 | Insider transaction | Mar 5, 2024 | Mar 2, 2024 |
| 4 | Insider transaction | Mar 5, 2024 | Mar 2, 2024 |
| 144 | Notice of proposed sale | Mar 4, 2024 | — |
| S-3ASR | Automatic shelf registration | Feb 28, 2024 | — |
| S-8 | Employee stock plan registration | Feb 28, 2024 | — |
| 10-K | Annual report | Feb 28, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Results of operations
|
Feb 28, 2024 | Feb 28, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 13, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Jan 24, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Jan 10, 2024 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Dec 13, 2023 | Dec 12, 2023 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Dec 11, 2023 | Dec 11, 2023 |
| 4 | Insider transaction | Dec 7, 2023 | Dec 5, 2023 |
| 8-K |
Current report
Officer or director change
|
Nov 22, 2023 | Nov 16, 2023 |
| 4 | Insider transaction | Nov 16, 2023 | Nov 14, 2023 |
| 4 | Insider transaction | Nov 9, 2023 | Nov 7, 2023 |
| 10-Q | Quarterly report | Nov 3, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 3, 2023 | Nov 3, 2023 |
| 8-K |
Current report
Officer or director change
|
Oct 10, 2023 | Oct 3, 2023 |
| 4 | Insider transaction | Sep 7, 2023 | Sep 6, 2023 |
| 4 | Insider transaction | Aug 15, 2023 | Aug 11, 2023 |
| 4 | Insider transaction | Aug 10, 2023 | Aug 8, 2023 |
| SC 13G | Ownership over 5% (passive) | Aug 4, 2023 | — |
| 10-Q | Quarterly report | Aug 2, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 2, 2023 | Aug 2, 2023 |
| 4 | Insider transaction | Jul 25, 2023 | Jul 24, 2023 |
| 3 | Initial insider ownership | Jul 25, 2023 | Jul 24, 2023 |
| 4 | Insider transaction | Jul 21, 2023 | Jul 19, 2023 |
| 8-K |
Current report
Material agreement, Other events
|
Jun 15, 2023 | Jun 14, 2023 |
| 424B5 | Prospectus supplement | Jun 15, 2023 | — |
| 424B5 | Prospectus supplement | Jun 14, 2023 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 9, 2023 | Jun 9, 2023 |
| 4 | Insider transaction | Jun 7, 2023 | Jun 5, 2023 |
| 4 | Insider transaction | Jun 7, 2023 | Jun 5, 2023 |
| 4 | Insider transaction | Jun 5, 2023 | Jun 1, 2023 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- EDIT (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Cambridge, MA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1650664
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.